Pharmaceutical Company Claris Lifesciences has sold its injectibles business to the US based Baxter. The deal is priced at USD 625 million and will be completed by the second half of 2017.
first published: Dec 15, 2016 05:15 pm
A collection of the most-viewed Moneycontrol videos.
The Lawyer Renting in one of Mumbai’s most green societies | The Tenant
Live: Nifty extends gain for the third day, up nearly 2% this week | Closing Bell | 4K
From renewables to AI and SMEs: Madhusudan Kela on where he senses opportunity now
Will The Pre-Diwali Nifty Rally Rage On Amid Weak Global Cues? RIL Q2 in Focus | Opening Bell Live
